Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
Retinal nerve fibre layer and brain grey substance as early prognostic factors for disability in multiple sclerosis.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Magnetic Resonance Imaging Predictors of Executive Functioning in Patients with Pediatric-Onset Multiple Sclerosis.
Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Falls and physical activity in persons with multiple sclerosis.
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
Mitochondrial dysfunction in central nervous system white matter disorders.
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Concepts for regulation of axon integrity by enwrapping glia.
Pages
« first
‹ previous
…
261
262
263
264
265
266
267
268
269
…
next ›
last »